Journal profile · Biochemistry & Molecular Biology
Applied Biochemistry and Biotechnology
ISSN 0273-2289 · eISSN 1559-0291 · Springer US · UNITED STATES · Semimonthly · Founded 1976
Applied Biochemistry and Biotechnology: CAS Zone 3 · Biology (2025 upgraded edition); impact factor 3.51; hybrid open access; APC about USD 3,890; median 124 days to acceptance (19 articles, last 24 months); community-reported acceptance: 57%; 349 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Applied Biochemistry and Biotechnology is published by Springer US and is in Zone 3 of Biology in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Biofuel production and bioconversion, Microbial Metabolic Engineering and Bioproduction and Enzyme Catalysis and Immobilization, together about 43.7% of its articles. Its main subfields are Molecular Biology. (generated from OpenAlex topic counts and CAS ranking data)
Applied Biochemistry and Biotechnology is devoted to publishing innovative papers in the fields of biochemistry and biotechnology. Though the typical focus of the journal is to report applications of novel scientific and technological breakthroughs, quality papers on technological subjects that are still in the proof-of-concept stage will also be considered. In addition, Applied Biochemistry and Biotechnology will provide a forum for practical concepts of biotechnology, utilization, including controls, statistical data analysis, problem descriptions unique to a particular application, and bioprocess economic analyses. In this regard, case studies are of particular interest. Applied Biochemistry and Biotechnology accepts previously unpublished work dealing with any of the areas of interest outlined above. Pertinent reviews of special interest to its readers will be considered. Meeting and symposia notices, and news items relating to biotechnology in both the industrial and academic communities are welcome. In addition, we often publish a list of patents and publications of special interest to our readers.
From the journal's Aims & Scope
Research area (LetPub): Biochemistry & Molecular Biology
Editor-in-chief Matthew P. DeLisaPublisher website
Editorial board by country: 13 in mainland China (about 25%); most named Mainland China 13, India 12, United States 11, Canada 5, Japan 2 (51 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Biofuel production and bioconversionEngineering18.2%
- Microbial Metabolic Engineering and BioproductionBiochemistry, Genetics and Molecular Biology13%
- Enzyme Catalysis and ImmobilizationBiochemistry, Genetics and Molecular Biology12.4%
- Enzyme Production and CharacterizationBiochemistry, Genetics and Molecular Biology10.4%
- Microbial Metabolites in Food BiotechnologyNursing3.9%
- Algal biology and biofuel productionEnergy3.7%
- Electrochemical sensors and biosensorsEngineering3.5%
- Enzyme-mediated dye degradationAgricultural and Biological Sciences3.3%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Biology Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Biology | Zone 3 |
| Minor | Biotechnology & Applied Microbiology | Zone 3 |
| Minor | Biochemistry & Molecular Biology | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Biology Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Biology | Zone 3 |
| Minor | Biochemistry & Molecular Biology | Zone 3 |
| Minor | Biotechnology & Applied Microbiology | Zone 3 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Biology Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Biology | Zone 4 |
| Minor | Biochemistry & Molecular Biology | Zone 4 |
| Minor | Biotechnology & Applied Microbiology | Zone 4 |
Top journal: noReview journal: no
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
EI CompendexMEDLINEEmbaseCASCAB AbstractsCurrent ContentsPublisher website
Other: Google Scholar, EBSCO, ProQuest, Dimensions, CNKI, Baidu, AGRICOLA, Naver, OCLC, Portico, CLOCKSS, Semantic Scholar
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 3.51LetPub ·
- Impact factor (publisher) 2025
- 3.5Publisher website ·
- 5-year impact factor (publisher) 2025
- 3.5Publisher website ·
- CiteScore 2026-06
- 7.7LetPub ·
- SJR 2026-06
- 0.68LetPub ·
- SNIP 2026-06
- 0.84LetPub ·
- h-index
- 97LetPub ·
- h-index
- 170OpenAlex ·
- i10-index
- 7,199OpenAlex ·
- 2-year mean citedness
- 3.01OpenAlex ·
- Self-citation rate
- 0%LetPub ·
- Share of gold OA articles
- 6.23%LetPub ·
Volume
- Articles per year
- 341LetPub ·
- Downloads per year (publisher) 2025
- 1,200,000Publisher website ·
Articles by year OpenAlex count · 11,542 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 440 | 51 | 159 |
| 2025 | 349 | 47 | 1,116 |
| 2024 | 311 | 34 | 2,038 |
| 2023 | 506 | 44 | 5,801 |
| 2022 | 518 | 69 | 8,882 |
| 2021 | 277 | 40 | 5,206 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
124 daysMedian, submission to acceptance · P25–P75 72 days – 140 days
- Acceptance to online
- median 12 days (153 articles)
- Submission to online
- median 131 days
- Sample
- 19 articles with submission and acceptance dates (995 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 6 monthsLetPub ·
- Average acceptance (community reports)
- 57%LetPub ·
- Submission to first decision
- 15 daysPublisher website ·
- Peer review
- Single anonymous peer review, Double anonymous peer reviewPublisher website
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
A subscription journal in which authors can pay to publish their article open access.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 3,890 / EUR 2,990 / GBP 2,590 | — | — | |
| Publisher website | No APC | — | — |
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
Other charges and waivers (author guidelines)
- Other fees
- No other fees
- Page charges
- No page charges
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
Open calls for papers1, by deadline
Publisher websiteWhat to prepare9 items from the author guidelines
- Abstract
- 150–250 words
- Keywords
- ≥ 4
- Manuscript length
- ≤ 1,000 words
- Reference style
- Numbered, in order of citation
- First submission
- Free format: the journal's layout is not required
- Suggested reviewers
- Required, 3
- Highlights
- Optional
- Graphical abstract
- Optional
- Cover letter
- Required
Article types accepted6, with length limits
- editorialSingle-blind peer review This journal follows a single-blind reviewing procedure. All submitted manuscripts are assigned by the authors to a journal section upo…Length not stated
- mini-reviewsReview articles and mini-reviews are most welcome.Length not stated
- original investigationsApplied Biochemistry and Biotechnology welcomes original investigations, short communications and review articles.Length not stated
- review articlesApplied Biochemistry and Biotechnology welcomes original investigations, short communications and review articles.Length not stated
- short communicationabstract of up to 100 words. In total a short communication should be no longer than 1000 words in length and should contain no more than three to four figmain text ≤ 1,000 words
- short communicationsApplied Biochemistry and Biotechnology welcomes original investigations, short communications and review articles.Length not stated
Policy excerpts from the journal's websiteAI use, Authorship, Conflicts of interest, Data availability, Publication ethics, License & copyright, Open access, Peer review, Trial registration / reporting guidelines
- AI use Generative AI Images
Please check Springer’s policy on generative AI images and make sure your work adheres to the principles described therein. Back to top
Source ↗Publisher website ·- Authorship Authorship principles
No page charges Model summary
These guidelines describe authorship principles and good authorship practices to which prospective authors should adhere to. Authorship clarified The Journal and Publisher assume all authors agreed with the content and that all gave explicit consent to submit and that they obtained consent from the responsible authorities at the institute/organization where the work has been carried out, before th…
Source ↗Publisher website ·- Conflicts of interest Disclosures and declarations
All authors are requested to include information regarding sources of funding, financial or non-financial interests, study-specific approval by the appropriate ethics committee for research involving humans and/or animals, informed consent if the research involved human participants, and a statement on welfare of animals if the research involved animals (as appropriate). The decision whether such …
Source ↗Publisher website ·- Data availability Data availability statements
All original research must include a data availability statement. This statement should explain how to access data supporting the results and analysis in the article, including links/citations to publicly archived datasets analysed or generated during the study. Please see our full policy here. If it is not possible to share research data publicly, for instance when individual privacy could be com…
Source ↗Publisher website ·- Publication ethics Compliance with Ethical Standards
To ensure objectivity and transparency in research and to ensure that accepted principles of ethical and professional conduct have been followed, authors should include information regarding sources of funding, potential conflicts of interest (financial or non-financial), informed consent if the research involved human participants, and a statement on welfare of animals if the research involved an…
Source ↗Publisher website ·- License & copyright License to Publish
Corresponding authors and/or the co-authors of a paper in production failing to complete the License to Publish form despite multiple reminders by Springer Nature should be aware their paper will be removed from production. Authors may request that their paper be reinstated one more time under a new DOI. Back to top
Source ↗Publisher website ·- Open access Open access publishing
To find out more about publishing your work Open Access in Applied Biochemistry and Biotechnology, including information on fees, funding and licences, visit our Open access publishing page. Back to top
Source ↗Publisher website ·- Peer review Single-blind peer review
Single-blind peer review Model summary
This journal follows a single-blind reviewing procedure. All submitted manuscripts are assigned by the authors to a journal section upon submission. If the manuscript's subject matter does not align with the selected section, an Editor-in-Chief may reassign it to a more appropriate section. Manuscripts are initially assessed by the EiC responsible for the assigned section. The EiC may then assign …
Source ↗Publisher website ·- Trial registration / reporting guidelines Clinical Trial Registration
The World Health Organization (WHO) definition of a clinical trial is "any research study that prospectively assigns human participants or groups of humans to one or more health-related interventions to evaluate the effects on health outcomes". The WHO defines health interventions as “A health intervention is an act performed for, with or on behalf of a person or population whose purpose is to ass…
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Springer US
- Country or region
- UNITED STATES
- Language
- English
- Frequency
- Semimonthly
- Founded
- 1976
- ISSN
- 0273-2289
- Electronic ISSN
- 1559-0291
- Latest issue on the website
- Volume 198, Issue 9 (September 2026)
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗Publisher website
- Author guidelines ↗LetPub
- Special issues ↗Publisher website
FAQ
Frequently asked questions about Applied Biochemistry and Biotechnology
What CAS zone is Applied Biochemistry and Biotechnology in?
In the 2025 upgraded edition of the CAS Journal Ranking, Applied Biochemistry and Biotechnology is in Zone 3 of Biology, and in Zone 3 of the minor category Biotechnology & Applied Microbiology / Biochemistry & Molecular Biology. In the 2026 Xinrui edition it is in Zone 3 of Biology. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Applied Biochemistry and Biotechnology?
The latest impact factor listed by LetPub is 3.51; CiteScore 7.7, h-index 170.
How long does peer review take at Applied Biochemistry and Biotechnology?
Based on the dates recorded on 19 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 124 days (interquartile range 72–140 days); authors report an average review time of about 6 months; the community-reported acceptance is “57%”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of Applied Biochemistry and Biotechnology?
According to the journal's author guidelines: Abstract: 150–250 words; Keywords: ≥ 4; Manuscript length: ≤ 1,000 words; Reference style: Numbered, in order of citation; First submission: Free format: the journal's layout is not required; Suggested reviewers: Required, 3; Highlights: Optional; Graphical abstract: Optional; Cover letter: Required. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of Applied Biochemistry and Biotechnology based?
Of the 51 board members whose country the journal's board page names, 13 (about 25%) are in mainland China; the countries named most often are Mainland China (13), India (12) and United States (11). Counted from the institutions listed on the board page; for reference only.
Which databases index Applied Biochemistry and Biotechnology?
According to LetPub and DOAJ records, Applied Biochemistry and Biotechnology is indexed in SCIE and Scopus. The journal's website also lists EI Compendex, MEDLINE, Embase, CAS, CAB Abstracts and Current Contents; that list has not been checked against each database.
Is Applied Biochemistry and Biotechnology open access, and what is the APC?
Applied Biochemistry and Biotechnology is a hybrid journal. For open-access publication: APC about USD 3,890.
Sources and updates
The facts on this page come from LetPub, OpenAlex, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .